Skip to content

Author

Wanying Xiang

We have 1 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Targeting the PHB2–ACSL3 Lipid‐Remodeling Axis Overcomes Cisplatin Resistance by Restoring Ferroptosis in Gastric Cancer

A PHB2–ACSL3 lipid‐metabolic axis that drives ferroptosis escape is defined and Mavorixafor repurposing is identified as an immediately translatable strategy to overcome cisplatin resistance in treatment‐refractory GC.

Liang Xu, Wanying Xiang, Xinyue Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.